Patent application number | Description | Published |
20140066622 | Imidazo[5,1-f][1,2,4]Triazines For The Treatment of Neurological Disorders - The present invention relates to compounds of the Formula | 03-06-2014 |
20140080806 | PYRAZOLO[3,4-D]PYRIMIDINE COMPOUNDS AND THEIR USE AS PDE2 INHIBITORS AND/OR CYP3A4 INHIBITORS - The present invention provides, inter alia, compounds of Formula (I) and pharmaceutically acceptable salts thereof, to processes for the preparation of, intermediates used in the preparation of and compositions containing such compounds and the uses of such compounds as a method for the treatment of a disease or condition selected from the group consisting of central nervous system disorders, cognitive disorders, schizophrenia, dementia and other disorders in a mammal. The present invention further provides compounds of Formula (Id) and pharmaceutically acceptable salts thereof as CYP3A4 selective inhibitors. | 03-20-2014 |
20140235612 | Azabenzimidazole Compounds - The present invention is directed to compounds of formula I: | 08-21-2014 |
20140329820 | Triazine Derivatives - The present invention is directed to a new class of triazine derivatives as described by formula I below in which A, X, R | 11-06-2014 |
20150080401 | Triazine Derivatives - The present invention is directed to a new class of triazine derivatives as described by formula I below in which A, X, R | 03-19-2015 |
20150322065 | Azabenzimidazole Compounds - The present invention is directed to compounds of formula I: | 11-12-2015 |
20150353579 | Triazine Derivatives - The present invention is directed to a new class of triazine derivatives as described by formula I below in which A, X, R | 12-10-2015 |
20160039828 | Imidazopyridazine Compounds - The present invention is directed to compounds of Formula I: | 02-11-2016 |